As we interact with our environment, there are definite changes in our epigenetic profile. This means that information from our surroundings (such as interactions with society and culture, use of internet, communication with people, reading etc.) is reflected on how our genes are ultimately expressed. Monozygotic (identical) twins who have been exposed to different environments have different epigenetic characteristics (1).
Information from the environment has an impact on DNA methylation, and it changes the expression of factors such as 5-methylcytosine (the methylated version of cytosine, which is involved in the regulation of gene transcription). An altered DNA methylation profile translates into health consequences (good or bad), depending on several other factors. We know that methylation (and 5-methylcytosine function) decreases with age (2). Although this process is variable, and some individuals may display a lesser degree of deterioration compared to others, it has been suggested by many researchers that maintaining DNA methylation is crucial to health. For example, age-related decrease in methylation can cause adult somatic cells to revert back to a stem-cell like status, which then predisposes to cancer (because the now young stem cells grow uncontrollably). But the issue of methylation is quite complicated because reduced methylation can have health benefits, too.
In any case, certain nutrients or compounds may modulate (increase or decrease) DNA methylation. One such example are the methyl donor molecules (compounds that carry and incorporate methyl groups onto the DNA molecule) betaine, methionine and choline. On the other hand, selenium, polyphenols and bioflavonoids (e.g. epigallocatechin-3-gallate, genistein, quercetin and fisetin) reduce methylation. A reduced methylation is not necessarily a bad thing, as it is the balance of methylation that counts. By following a well-adjusted mix of both promoting and decreasing factors, the body is allowed to make its own choices according to local needs, for optimum results. It is not a matter of just indiscriminately using pro-methylation compounds, expecting to inevitably experience health benefits. Biology is not as simple as that. The mechanisms rely on several mutually-balancing effects. There is significant cross-talk between cell metabolism and the epigenome, which balances homoeostasis for normal cell function. This depends on the ratio of hyper- vs hypo- methylation compounds, such as methionine and serine, as well as idebenone and SAMe (S-adenosyl-methionine, or SAM) which then affect ATP synthesis and function (3), (Figure 1).
Figure 1. Relationship between methionine, SAMe, ATP (adenosine tri-phosphate), and methylation. Other processes are also involved, and the entire reaction can proceed or slow down depending on the different factors. This shows that SAMe depends on ATP in order to function effectively, therefore some practitioners advise adding ATP supplements to a methylation regimen (3). After all, SAMe is a molecule composed of adenosine (which is derived from ATP) and methionine.
S-adenosyl-methionine Researches claimed that supplementation with SAMe and polyunsaturated fatty acids (PUFA) may be useful in reducing the impact of mild dementia (4). The researchers focused on dietary supplementation as applied both in pre-dementia syndromes and Alzheimer’s disease. They found that SAMe plays a critical role as a neuroprotective nutritional supplement, and that it works much better if it is used in association with other compounds, particularly PUFA. SAMe can also improve the mechanisms leading to the reprogramming of stem cells (5). This is achieved by enhancing the methylation and by fine-tuning the processes involved in stem cell function.
By the way, SAMe is also used against depression and can be as effective as prescription antidepressants (6). SAMe is involved in several biochemical reactions (such as those which methylate folate), donating methyl groups in order to methylate neurotransmitters (Figure 2). It was shown that a low concentration of SAMe in the cerebrospinal fluid is also associated with reduced levels of neurotransmitters, and is one of the biochemical reasons leading to clinical depression (7).
Figure 2. Human methyltransferase (the enzyme that catalyzes the transfer of methyl groups), in complex with SAMe. This image hints at the 3-D complexity of the molecules involved. In reality, the enzyme is much more complicated, functioning in 4 dimensions (over time) and, like all other enzymes, it is more accurately described as a ‘cloud-like’ ensemble structure.
In another study, idebenone (a synthetic equivalent of co-enzyme Q10), in association with resveratrol, improved DNA methylation and mitochondrial function in a model of Parkinson’s disease; the relevance of this finding is that it is best to use a suitable combination of compounds in order to address any given health problem. Many research projects repeatedly highlight the importance of using combinations, rather than single agents (8).
Chemical structure of Idebenone, ready to donate 2 methyl groups (CH3)
Idebenone is involved in both hyper- and hypo- methylation of genes, which results in regulated apoptosis and antioxidant protection. This, once again, shows that a health benefit related to methylation may be achieved not only through high or through low methylation, but through a balanced action (9). Idebenone is also an antioxidant which can modulate apoptosis (increases cell death in cancer, and decreases cell death in aging). It inhibits lipid peroxidation and can be used in the treatment or prevention of atherosclerosis (10).
Conclusions Health benefits result from both up- and down-regulation of methylation. So where does this leave us with regards to offering clinical advice on methylation supplements? Should we aim for a low dose, a high dose, or a compromise between the two? A few facts may seem relevant: The commonly-recommended methylation-enhancer compounds (such as SAMe, idebenone, methionine, etc.) appear to be a valid suggestion, but this does not mean that by taking a very high dose we should also expect a corresponding very beneficial result. A moderate dose in association with other supplements and a balanced diet, is a more reasonable option. If we provide our body with the raw materials, then nature will do the rest. But it is also important to maintain a good and active interest in our surroundings (which includes integration of technology, social interactions, and increased cognitive lifestyle). The information we are exposed to then results in suitable modifications of the DNA via methylation, leading to adaptations in our metabolism, making us healthier and better able to cope with the rigours of aging.
REFERENCES 1. Fraga et al. 2005. Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci U S A. 2005 Jul 26;102(30):10604-9 2. Heyn et al. Distinct DNA methylomes of newborns and centenarians.Proc Natl Acad Sci U S A. 2012 Jun 26;109(26):10522-7 3. Maddocks OD, Labuschagne CF, Adams PD, Vousden KH. Serine Metabolism Supports the Methionine Cycle and DNA/RNA Methylation through De Novo ATP Synthesis in Cancer Cells. Mol Cell. 2016 Jan 21; 61(2):210-21 4. Panza F, Frisardi V, Capurso C, et al. Polyunsaturated fatty acid and S-adenosylmethionine supplementation in predementia syndromes and Alzheimer's disease: a review. Scientific World Journal. 2009 May 22;9: 373-89 5. Fernández-Arroyo S, Cuyàs E, et al. Activation of the methylation cycle in cells reprogrammed into a stem cell-like state. Oncoscience. 2016 Jan 5;2(12):958-67 6. Sarris J, et al. S-adenosyl methionine (SAMe) versus escitalopram and placebo in major depression RCT: efficacy and effects of histamine and carnitine as moderators of response. J Affect Disord. 2014 Aug; 164:76-81 7. Miller AL.The methylation, neurotransmitter, and antioxidant connections between folate and depression. Altern Med Rev. 2008 Sep;13(3):216-26 8. Gerhardt E, et al. Idebenone and resveratrol extend lifespan and improve motor function of HtrA2 knockout mice. PLoS One. 2011;6(12):e28855 9. Quesada MP, et al. Novel aberrant genetic and epigenetic events in Friedreich's ataxia. Exp Cell Res. 2015 Jul 1; 335(1):51-61 10. Lin P, et al. Idebenone protects against oxidized low density lipoprotein induced mitochondrial dysfunction in vascular endothelial cells via GSK3β/β-catenin signalling pathways. Biochem Biophys Res Commun. 2015 Sep 25;465(3):548-55